PMDA drug package insert
ドブタミン持続静注50mgシリンジ「KKC」
PMDA Prescription drug · テルモ株式会社 · package insert Jul 26, 2021
Key facts
| Brand names | ドブタミン持続静注50mgシリンジ「KKC」, ドブタミン持続静注150mgシリンジ「KKC」, ドブタミン持続静注300mgシリンジ「KKC」 |
|---|---|
| Nonproprietary names | ドブタミン塩酸塩 |
| Companies | 製造販売元／テルモ株式会社, 販売元／協和キリン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 急性循環不全改善剤 |
| Therapeutic category codes | 872119 |
| YJ codes | 2119404G5040, 2119404G6047, 2119404G7035 |
| Approval numbers | 30200AMX00736, 30200AMX00737, 30200AMX00738 |
| Package insert edition | 第1版 |
| Package insert date | Jul 26, 2021 |
| PMDA document key | 470034_2119404G6047_1 |
| PMDA company code | 470034 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: